CVA Family Office’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $750K | Sell |
9,475
-1,479
| -14% | -$117K | 0.11% | 120 |
|
|
2025
Q1 | $983K | Sell |
10,954
-71
| -0.6% | -$6.37K | 0.15% | 99 |
|
|
2024
Q4 | $1.1M | Buy |
11,025
+422
| +4% | +$42K | 0.17% | 85 |
|
|
2024
Q3 | $1.2M | Sell |
10,603
-69
| -0.6% | -$7.84K | 0.2% | 81 |
|
|
2024
Q2 | $1.32M | Sell |
10,672
-355
| -3% | -$43.9K | 0.24% | 71 |
|
|
2024
Q1 | $1.46M | Buy |
11,027
+90
| +0.8% | +$11.9K | 0.26% | 66 |
|
|
2023
Q4 | $1.19M | Sell |
10,937
-134
| -1% | -$14.6K | 0.23% | 72 |
|
|
2023
Q3 | $1.14M | Buy |
11,071
+6
| +0.1% | +$618 | 0.26% | 71 |
|
|
2023
Q2 | $1.28M | Buy |
11,065
+800
| +8% | +$92.3K | 0.27% | 63 |
|
|
2023
Q1 | $1.09M | Sell |
10,265
-52
| -0.5% | -$5.53K | 0.24% | 66 |
|
|
2022
Q4 | $1.14M | Buy |
10,317
+359
| +4% | +$39.8K | 0.28% | 62 |
|
|
2022
Q3 | $858K | Buy |
9,958
+2,148
| +28% | +$185K | 0.23% | 74 |
|
|
2022
Q2 | $712K | Buy |
7,810
+291
| +4% | +$26.5K | 0.19% | 85 |
|
|
2022
Q1 | $617K | Buy |
7,519
+2,016
| +37% | +$165K | 0.15% | 90 |
|
|
2021
Q4 | $422K | Buy |
5,503
+12
| +0.2% | +$920 | 0.11% | 109 |
|
|
2021
Q3 | $455K | Sell |
5,491
-1,888
| -26% | -$156K | 0.33% | 52 |
|
|
2021
Q2 | $574K | Buy |
7,379
+513
| +7% | +$39.9K | 0.16% | 85 |
|
|
2021
Q1 | $505K | Buy |
6,866
+998
| +17% | +$73.4K | 0.19% | 74 |
|
|
2020
Q4 | $458K | Buy |
5,868
+113
| +2% | +$8.82K | 0.28% | 59 |
|
|
2020
Q3 | $455K | Buy |
5,755
+693
| +14% | +$54.8K | 0.33% | 52 |
|
|
2020
Q2 | $373K | Buy |
5,062
+520
| +11% | +$38.3K | 0.31% | 55 |
|
|
2020
Q1 | $333K | Buy |
4,542
+464
| +11% | +$34K | 0.34% | 55 |
|
|
2019
Q4 | $354K | Buy |
+4,078
| New | +$354K | 0.33% | 54 |
|